1999
Biliary Tract Obstruction Secondary to Mycosis Fungoides: A Case Report
Madsen J, Tallini G, Glusac E, Salem R, Braverman I, Robert M. Biliary Tract Obstruction Secondary to Mycosis Fungoides: A Case Report. Journal Of Clinical Gastroenterology 1999, 28: 56-60. PMID: 9916670, DOI: 10.1097/00004836-199901000-00015.Peer-Reviewed Original ResearchConceptsExtrahepatic biliary treeMycosis fungoidesBiliary treeObstructive jaundiceCutaneous T-cell lymphomaMonoclonal T-cell populationMixed lymphocytic infiltratePrevious skin biopsiesBiliary tract obstructionT cell populationsT-cell lymphomaGene rearrangement studiesObstructive symptomsTract obstructionLiver involvementSurgical resectionIsolated involvementLymphocytic infiltrateEndoscopic examinationExtrahepatic ductsAtypical cellsCase reportSkin biopsiesFungoidesMultiple organs
1997
Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides)
Quirós P, Jones G, Kacinski B, Braverman I, Heald P, Edelson R, Wilson L. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). International Journal Of Radiation Oncology • Biology • Physics 1997, 38: 1027-1035. PMID: 9276369, DOI: 10.1016/s0360-3016(97)00127-2.Peer-Reviewed Original ResearchConceptsTotal skin electron beam therapyDisease-free survivalT2 patientsCrude relapse rateAdjuvant therapyOverall survivalElectron beam therapyRelapse rateEntire cohortMedian disease-free survivalCutaneous T-cell lymphomaBeam therapySalvage of recurrencesAdjuvant systemic therapyEarly-stage patientsManagement of patientsT-cell lymphomaTopical nitrogen mustardDays/weekCombination of therapiesGy/dayTreatments/weekPUVA patientsMedian followSalvage therapy
1995
Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy
Wilson L, Licata A, Braverman I, Edelson R, Heald P, Feldman A, Kacinski B. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy. International Journal Of Radiation Oncology • Biology • Physics 1995, 32: 987-995. PMID: 7607973, DOI: 10.1016/0360-3016(95)00073-8.Peer-Reviewed Original ResearchConceptsTotal skin electron beam therapyDoxorubicin/cyclophosphamideCutaneous T-cell lymphoma patientsAdjuvant doxorubicin/cyclophosphamideT-cell lymphoma patientsExtracorporeal photochemotherapyComplete responseOverall survivalAdjuvant therapyElectron beam therapyAdjuvant regimenFree survivalCTCL patientsLymphoma patientsBeam therapyAddition of chemotherapyAdvanced stage CTCLClinical complete responseSystemic adjuvant therapyGood partial responseSignificant survival benefitBetter overall survivalRelapse-free survivalSoles of feetNontoxic regimenHypopigmented variant of mycosis fungoides: Demography, histopathology, and treatment of seven cases
Lambroza E, Cohen S, Phelps R, Lebwohl M, Braverman I, DiCostanzo D. Hypopigmented variant of mycosis fungoides: Demography, histopathology, and treatment of seven cases. Journal Of The American Academy Of Dermatology 1995, 32: 987-993. PMID: 7751470, DOI: 10.1016/0190-9622(95)91337-8.Peer-Reviewed Original ResearchMeSH KeywordsAdultBlack PeopleFemaleHumansHypopigmentationMaleMycosis FungoidesPUVA TherapySkinSkin NeoplasmsConceptsMycosis fungoidesEpidermal atrophyVariant of MFTreatment of choiceMedian ageMononuclear cellsHistologic findingsBiopsy diagnosisComplete repigmentationDisease onsetTreatment outcomesMF variantDisease processNew casesYoung populationPrior reportsFungoidesPUVAPatientsAtrophyMicroscopic featuresHistopathologyTreatmentDark skinSkin
1993
Transformation in Cutaneous T-Cell Lymphoma
Braverman I, Redfern C. Transformation in Cutaneous T-Cell Lymphoma. Journal Of Investigative Dermatology 1993, 101: 249-251. PMID: 8370959, DOI: 10.1111/1523-1747.ep12365124.Peer-Reviewed Original Research
1988
Progression of pigmented purpura-like eruptions to mycosis fungoides: Report of three cases
Barnhill R, Braverman I. Progression of pigmented purpura-like eruptions to mycosis fungoides: Report of three cases. Journal Of The American Academy Of Dermatology 1988, 19: 25-31. PMID: 3403742, DOI: 10.1016/s0190-9622(88)70147-4.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultDermatitisDiagnosis, DifferentialHumansMaleMycosis FungoidesPigmentation DisordersPurpuraSkin Neoplasms
1987
Combined total body electron beam irradiation and chemotherapy for mycosis fungoides
Braverman I, Yager N, Chen M, Cadman E, Hait W, Maynard T. Combined total body electron beam irradiation and chemotherapy for mycosis fungoides. Journal Of The American Academy Of Dermatology 1987, 16: 45-60. PMID: 3100583, DOI: 10.1016/s0190-9622(87)70004-8.Peer-Reviewed Original ResearchConceptsComplete clinical remissionElectron beam therapyMycosis fungoidesClinical remissionBeam therapyKaplan-Meier methodElevated blood levelsSignificant differencesGeneralized Wilcoxon testSézary cellsCombination therapyBlood levelsControl subjectsActuarial analysisStage IStage IIIPatientsFungoidesTherapyKaryotypic abnormalitiesMonthly cyclesWilcoxon testRemissionChemotherapyStatistical analysisElectron microscopic and immunolabeling studies of the lesional and normal skin of patients with mycosis fungoides treated by total body electron beam irradiation
Braverman I, Klein S, Grant A. Electron microscopic and immunolabeling studies of the lesional and normal skin of patients with mycosis fungoides treated by total body electron beam irradiation. Journal Of The American Academy Of Dermatology 1987, 16: 61-74. PMID: 3100584, DOI: 10.1016/s0190-9622(87)70005-x.Peer-Reviewed Original ResearchConceptsEpidermal Langerhans cellsElectron beam therapyLangerhans cellsMycosis fungoidesIndeterminate cellsNormal skinDisease courseLesional skinBeam therapySkin lesionsNonspecific skin lesionsPatient's disease courseIa-positive cellsEpidermal cell suspensionsEpidermal thymocyteClinical remissionBiopsy specimensPretreatment levelsIa antigensFungoidesTherapyLesionsSkinPatientsCells
1981
An unusual and fatal case of disseminated cutaneous herpes simplex Infection in a patient with cutaneous T cell lymphoma (mycosis fungoides)
Goldgeier M, Cohen S, Braverman I, Stenn K. An unusual and fatal case of disseminated cutaneous herpes simplex Infection in a patient with cutaneous T cell lymphoma (mycosis fungoides). Journal Of The American Academy Of Dermatology 1981, 4: 176-180. PMID: 7217388, DOI: 10.1016/s0190-9622(81)70021-5.Peer-Reviewed Original ResearchMeSH KeywordsFemaleHerpes SimplexHumansMiddle AgedMycosis FungoidesPrognosisSkin Diseases, InfectiousSkin NeoplasmsSkin UlcerVidarabineConceptsHerpes simplex infectionMycosis fungoidesSimplex infectionViral cultureCutaneous herpes simplex virus infectionCutaneous herpes simplex infectionCutaneous T-cell lymphomaHerpes simplex virus infectionPlaque stage mycosis fungoidesSerial antibody titersSimplex virus infectionStage mycosis fungoidesT-cell lymphomaCutaneous ulcersImmunocompromised hostCutaneous ulcerationAntibody titersFatal casesTzanck preparationVesicular lesionsHistologic examinationVirus infectionCell lymphomaSkin lesionsHerpes virus
1980
Mycosis fungoides: Clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor
Cohen S, Stenn K, Braverman I, Beck G. Mycosis fungoides: Clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor. Cancer 1980, 46: 2654-2666. PMID: 6778603, DOI: 10.1002/1097-0142(19801215)46:12<2654::aid-cncr2820461220>3.0.co;2-1.Peer-Reviewed Original ResearchConceptsStage of diseaseMycosis fungoidesPatient survivalClinicopathologic relationshipOccupational factorsSignificant prognostic variablesNew prognostic factorsCase-control studyPrognostic factorsPathogenic hypothesisSézary cellsHistologic stageHistopathologic materialVisceral manifestationsHistologic criteriaChemotherapeutic modalitiesSevere diseaseSkin lesionsPrognostic variablesSkin tumorsProbability of survivalFurther evaluationPatientsDiseaseStaging scheme